Chester County News and Community Website
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX), announced recently that the Company has engaged Torreya Capital, LLC (Torreya) to serve as the exclusive financial advisor for the Company’s partnering …
Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from …
Read More
MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced significant recent progress in strengthening the company’s business development team to support its strategic objective of expanding and diversifying its customer …
Read More
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced that it advanced its …
Read More
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, this week announced the closing of …
Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that it intends to offer and sell, subject …
Read More
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, this week reported financial results for …
Read More
BERWYN, PA — Amring Pharmaceuticals Inc. (Amring), a niche brand and generic pharmaceutical company, announced an agreement with Amzell B.V. (Amzell) that will further strengthen its position in the marketplace …
Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX ) recently announced financial results for the fourth quarter and year ended December 31, 2020, and highlighted recent corporate accomplishments.
Read More